DXR - MCAP CO - Daxor Corporation

Daxor Corporation (DXR) is expanding the presence of BVA-100 systems in US clinics, focusing on direct supplies and winning hospital tenders without mergers. This price chart from GURU.Markets, where the market capitalization stands at 0.06, visualizes the asset's price action. Business growth is driven by the integration of rapid blood analysis into heart failure therapy standards and the precision of the equipment.

To minimize investment risks, it is necessary to separate market noise from the asset's fundamental value. Market capitalization is calculated as the product of the current share price and the total number of outstanding shares, measuring the aggregate market value of the business. By analyzing the history of a company's market capitalization, an investor identifies long-term ownership trends. For Daxor Corporation (DXR), this indicator demonstrates high resilience. Stable demand for cardiology diagnostics offsets seasonal fluctuations, confirming the issuer's macroeconomic strength.